Mamoru Ito Selected Research

Leukemic Infiltration

1/2006	Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
5/2003	Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mamoru Ito Research Topics

Disease

32	Neoplasms (Cancer) 10/2022 - 05/2003
8	Infections 04/2017 - 08/2003
6	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2017
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 10/2018
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2014 - 11/2002
5	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2007
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2012
4	Hypersensitivity (Allergy) 01/2021 - 07/2005
4	Thrombocytopenia (Thrombopenia) 01/2020 - 08/2008
4	Leukemia 01/2014 - 01/2006
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 02/2005
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 06/2009
3	Body Weight (Weight, Body) 01/2019 - 09/2006
3	Insulin Resistance 01/2011 - 06/2006
3	Glucose Intolerance 01/2011 - 06/2006
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022 - 09/2018
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 12/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2018
2	Disease Progression 12/2020 - 10/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 10/2007
2	Ischemia 11/2019 - 01/2011
2	Inflammation (Inflammations) 01/2019 - 11/2018
2	Hyperplasia 11/2018 - 03/2002
2	Ascites 11/2018 - 09/2018
2	Glioblastoma (Glioblastoma Multiforme) 10/2017 - 01/2017
2	Hypoxia (Hypoxemia) 08/2015 - 01/2011
2	Pathologic Constriction (Stenosis) 02/2014 - 01/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014 - 08/2006
2	Virus Diseases (Viral Diseases) 01/2008 - 01/2007
2	Leukemic Infiltration 01/2006 - 05/2003
2	T-Cell Leukemia (Leukemia, T Cell) 01/2006 - 05/2003
1	Hemorrhage 10/2022
1	Venous Thromboembolism 10/2022
1	Thromboembolism 10/2022
1	Bronchiolitis Obliterans Syndrome 11/2021
1	Pneumonia (Pneumonitis) 10/2021
1	Dyspnea (Shortness of Breath) 10/2021
1	Lymphatic Metastasis 05/2021
1	Cerebral Toxoplasmosis 04/2021
1	Immune Reconstitution Inflammatory Syndrome 04/2021
1	Paresis (Hemiparesis) 04/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2007
4	NivolumabIBA 10/2021 - 01/2020
4	CytokinesIBA 11/2018 - 06/2003
3	Monoclonal AntibodiesIBA 10/2021 - 09/2006
3	Biological ProductsIBA 05/2021 - 11/2018
3	Immunoglobulin E (IgE)IBA 01/2021 - 06/2003
3	LigandsIBA 10/2020 - 03/2003
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 06/2017
3	AntibodiesIBA 12/2019 - 01/2007
3	AntigensIBA 11/2018 - 01/2012
3	Interleukin Receptor Common gamma SubunitIBA 06/2014 - 02/2005
3	NF-kappa B (NF-kB)IBA 08/2005 - 05/2003
2	HLA-DR Antigens (HLA-DR)IBA 11/2021 - 01/2014
2	eribulin FDA Link 10/2021 - 12/2020
2	SteroidsIBA 10/2021 - 08/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 03/2003
2	C-Reactive ProteinIBA 01/2021 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2018
2	Lactoglobulins (beta-Lactoglobulin)FDA Link 01/2021 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 05/2017
2	Immune Checkpoint ProteinsIBA 10/2020 - 12/2019
2	Bevacizumab (Avastin)FDA Link 01/2020 - 11/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 06/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2006
2	Immune Checkpoint InhibitorsIBA 12/2019 - 09/2018
2	STX-0119IBA 12/2019 - 10/2017
2	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 06/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2018 - 09/2013
2	Interleukin-13IBA 11/2018 - 06/2003
2	Immunoglobulin G (IgG)IBA 11/2018 - 01/2017
2	EnzymesIBA 11/2018 - 06/2006
2	Immunoglobulins (Immunoglobulin)IBA 09/2018 - 02/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 08/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 07/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 06/2006
2	InterleukinsIBA 11/2009 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 08/2005
2	Tumor Biomarkers (Tumor Markers)IBA 08/2005 - 07/2004
1	Dabigatran FDA Link 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Thrombin FDA Link 01/2022
1	OsteopontinIBA 01/2022
1	Antinuclear AntibodiesIBA 11/2021
1	pazopanib FDA Link 10/2021
1	TrabectedinIBA 10/2021
1	Infliximab (Remicade)FDA Link 10/2021
1	human ERBB2 proteinIBA 01/2021
1	AllergensIBA 01/2021

Therapy/Procedure

21	Therapeutics 10/2022 - 08/2006
9	Drug Therapy (Chemotherapy) 10/2022 - 01/2006
5	Transplantation 01/2019 - 01/2004
3	Heterologous Transplantation (Xenotransplantation) 08/2006 - 11/2002
2	Immunotherapy 01/2017 - 01/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2012 - 04/2003
1	Genomic Medicine 07/2021